glp 1 agonists vs sglt2 inhibitors Full article: Combination inhibitor and GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes Use of GLP-1 Receptor Agonists

Cavallini G et al

doi: 10.3389/fphar.2021.718147 Received 09 June 2021 Accepted 17 November 2021 Published 13 December 2021 Volume 12 - 2021 Edited by Fan Jiang, Shandong University, China Reviewed by Dechang Chen, Shanghai Jiao Tong University, China Ying Li, Xian Jiaotong University, China Updates Copyright 2021 Tepes, Gojkovic, Krezic, Zizek, Vranes, Madzar, Santak, Batelja, Milavic, Sikiric, Kocman, Simonji, Samara, Knezevic, Barisic, Lovric, Strbe, Kokot, Sjekavica, Kolak, Skrtic, Seiwerth, Boban Blagaic and Sikiric

Psychopharmacology 134 : 351353

R-spondins (RSPOs) are a family of four secretory proteins (RSPO1 to RSPO4)

Gs Weight Loss & Wellness in Boca Raton or request a consultation

M.AhmadJ